Rodems, Tamara S. http://orcid.org/0000-0001-6582-9379
Heninger, Erika
Stahlfeld, Charlotte N.
Gilsdorf, Cole S.
Carlson, Kristin N.
Kircher, Madison R.
Singh, Anupama
Krueger, Timothy E. G.
Beebe, David J. http://orcid.org/0000-0002-0415-9006
Jarrard, David F.
McNeel, Douglas G. http://orcid.org/0000-0003-1471-6723
Haffner, Michael C.
Lang, Joshua M. http://orcid.org/0000-0002-0943-8872
Funding for this research was provided by:
Office of the Assistant Secretary of Defense for Health Affairs through the Prostate Cancer Research Program
National Cancer Institute of the National Institutes of Health
Office of the Assistant Secretary of Defense for Health Affairs through the Prostate Cancer Research Program National Cancer Institute of the National Institutes of Health
Article History
Received: 2 November 2021
Accepted: 15 August 2022
First Online: 1 September 2022
Change Date: 16 September 2022
Change Type: Update
Change Details: In this article the editor statement was missing from the ‘Peer review information’, and should have read ‘Primary Handling Editor: Zhijuan Qiu’.
Competing interests
: J.M.L. and D.J.B. hold equity in Salus Discovery, which has licensed some of the technology described in the manuscript. D.J.B. also holds equity in BellBrook Labs LLC, Tasso Inc., Stacks to the Future LLC, Lynx Biosciences LLC, Onexio Biosystems LLC, Turba LLC, and is a consultant for Abbott Laboratories. The remaining authors declare no competing interests.